Histopathologie des réactions cutanées médicamenteuses

Posadas, 2007, Delayed drug hypersensitivity reactions – new concepts, Clin Exp Allergy J Br Soc Allergy Clin Immunol, 37, 989, 10.1111/j.1365-2222.2007.02742.x Tangamornsuksan, 2013, Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis, JAMA Dermatol, 149, 1025, 10.1001/jamadermatol.2013.4114 Hung, 2005, HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol, Proc Natl Acad Sci U S A, 102, 4134, 10.1073/pnas.0409500102 Mallal, 2008, HLA-B*5701 screening for hypersensitivity to abacavir, N Engl J Med., 358, 568, 10.1056/NEJMoa0706135 Nassif, 2004, Evaluation of the potential role of cytokines in toxic epidermal necrolysis, J Invest Dermatol., 123, 850, 10.1111/j.0022-202X.2004.23439.x Chung, 2008, Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis, Nat Med., 14, 1343, 10.1038/nm.1884 Viard, 1998, Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin, Science., 282, 490, 10.1126/science.282.5388.490 Bellón, 2010, Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases, Br J Dermatol, 162, 1014, 10.1111/j.1365-2133.2009.09627.x de Araujo, 2011, Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis, Exp Dermatol., 20, 107, 10.1111/j.1600-0625.2010.01176.x Saito, 2014, An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions, Sci Transl Med, 6, 10.1126/scitranslmed.3008227 Abe, 2003, Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand, Am J Pathol., 162, 1515, 10.1016/S0002-9440(10)64284-8 Takahashi, 2009, Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome, J Immunol Baltim Md 1950, 182, 8071 Mizukawa, 2008, In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption, Br J Dermatol, 158, 1230, 10.1111/j.1365-2133.2008.08516.x Pinto Gouveia, 2016, Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward, Br J Dermatol, 175, 1274, 10.1111/bjd.14704 Ortonne, 2016, Is DRESS syndrome a single entity or within a spectrum of adverse reactions to drug?, Br J Dermatol, 175, 1142, 10.1111/bjd.14986 Mizukawa, 2002, Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption, Am J Pathol, 161, 1337, 10.1016/S0002-9440(10)64410-0 Duong, 2017, Severe cutaneous adverse reactions to drugs, Lancet Lond Engl, 10.1016/S0140-6736(16)30378-6 Kardaun, 2013, Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study, Br J Dermatol, 169, 1071, 10.1111/bjd.12501 Gerson, 2008, Cutaneous drug eruptions: a 5-year experience, J Am Acad Dermatol, 59, 995, 10.1016/j.jaad.2008.09.015 Ortonne, 2015, Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study, Br J Dermatol, 173, 50, 10.1111/bjd.13683 Halevy, 2010, The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases, Br J Dermatol, 163, 1245, 10.1111/j.1365-2133.2010.09967.x Valeyrie-Allanore, 2013, Prognostic value of histologic features of toxic epidermal necrolysis, J Am Acad Dermatol, 68, e29, 10.1016/j.jaad.2011.10.007 Seishima, 2006, Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome, Br J Dermatol, 155, 344, 10.1111/j.1365-2133.2006.07332.x Picard, 2010, Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response, Sci Transl Med, 2, 10.1126/scitranslmed.3001116 Leclaire Alirkilicarslan, 2017, Expression of TFH markers and detection of RHOA p.G17V and IDH2 p.R172K/S mutations in cutaneous localizations of angioimmunoblastic T-cell lymphomas, Am J Surg Pathol, 10.1097/PAS.0000000000000956